Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.23.3
Stock-based Compensation (Tables)
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock based Compensation Expense

Stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 is as follows:

 

    2023     2022     2023     2022  
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2023     2022     2023     2022  
Cost of revenues   $ 28     $ 9     $ 230     $ 89  
Sales and marketing     90       3       222       53  
General and administrative     231       622       564       1,230  
Research and development     22       3       22       18  
 Stock-based compensation expenses   $ 371     $ 637     $ 1,038     $ 1,136  
Summary of Stock Option Activity

Stock option activity for the nine months ended September 30, 2023, is set forth in the table below:

 

          Weighted     Weighted average        
          average     remaining     Aggregate  
          exercise price     contractual life     Intrinsic  
    Options     per share     (in years)     Value*  
Outstanding at January 1, 2023     4,476,215     $ 0.95                            9.76     $ 358  
Options granted     1,483,000     $ 0.54                  
Options exercised     (1,000,000 )     0.42                  
Options forfeited     —                          
Options expired     (7,833 )     4.50                  
Outstanding at September 30, 2023     4,951,382     $ 0.93       9.12     $ 1,091  
                                 
Exercisable at September 30, 2023     403,420     $ 5.75       8.62     $ 89  

 

* The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the balance sheet date.
Schedule of Outstanding Restricted Stock Units

RSU activity for the nine months ended September 30, 2023, is set forth in the table below:

 

    RSUs  
Outstanding at January 1, 2023     860,888  
Granted     87,100  
Released     (605,392 )
Forfeited     (5,200 )
Outstanding at September 30, 2023     337,396